-
METTL16–SENP3–LTF Axis in HCC Ferroptosis
2026-08-13
Wang et al. identify a METTL16–SENP3–LTF regulatory axis that protects hepatocellular carcinoma cells from ferroptosis by controlling labile iron availability. The study combines molecular assays, organoids, xenografts, genetically engineered mice, and human samples to connect m6A-dependent RNA regulation with iron metabolism and tumor progression.
-
ER-Targeting Peptide Self-Assembly in Cancer Cells
2026-08-13
The reference study develops an alkaline-phosphatase-triggered peptide that self-assembles at the endoplasmic reticulum through a p-toluenesulfonamide targeting group. This design selectively increases ER stress and cancer-cell death while reducing the concentration dependence of earlier intracellular enzyme-instructed self-assembly strategies.
-
Glutathione Redox Logic in Hypoxic Tumors
2026-08-12
Hypoxia and immunometabolic competition can reshape tumor redox biology, but translational interpretation depends on measuring reduced and oxidized glutathione together. This thought-leadership guide connects mechanistic insight with a practical validation strategy using the GSH and GSSG Assay Kit.
-
Neomycin sulfate for RNA/DNA Assays
2026-08-12
Neomycin sulfate is more than an antimicrobial: its structure-selective effects support ribozyme, TAR, DNA-triplex, and ryanodine receptor assays. This workflow-led guide shows how to prepare aqueous stocks, separate genuine binding from ionic confounding, and use a rat allergic-rhinitis study as a careful model for multi-endpoint experimental design.
-
Biotin-16-UTP RNA Labeling Workflow
2026-08-11
Biotin-16-UTP provides a biotin-labeled uridine triphosphate for generating affinity-tagged RNA during in vitro transcription, supporting RNA detection and purification and downstream binding assays. It is intended for controlled research workflows only, not diagnostic or medical use, and requires cold storage and empirical optimization for each polymerase and RNA template.
-
AhR–RBX1/HSF1 Signaling in Acute Pancreatitis
2026-08-11
A 2025 study identifies an AhR–RBX1/HSF1 regulatory axis that links macrophage behavior, pancreatic acinar-cell stress, and tight-junction preservation during severe acute pancreatitis. Its combination of mouse modeling, primary-cell experiments, protein-interaction analysis, and pharmacological perturbation provides a mechanistic framework for studying epithelial barrier injury, while also highlighting unresolved questions about HSF1 regulation.
-
Olaparib: From PARP Trapping to Nascent-Strand Repair
2026-08-10
Olaparib and AZD2281 are examined through a replication-focused lens, connecting PARP trapping with BRCA2-dependent nascent-strand maturation. Learn how this 2026 finding can improve DNA damage response assay design, BRCA-associated cancer research, and radiosensitization studies.
-
DOTAP for Nucleic Acid Delivery and Immune Assays
2026-08-09
DOTAP combines electrostatic nucleic acid binding with adaptable liposomal delivery, making it useful for transient gene expression, functional genomics, and formulation screening. This workflow-focused guide shows how to apply it to immune-metabolism assays inspired by recent nano-zoledronate research while separating established product behavior from exploratory hypotheses.
-
BFH772 (VEGFR2 inhibitor): Lab Guide
2026-08-08
BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled studies of VEGFR2-mediated signaling and angiogenesis, including biochemical, cellular, and tumor-model workflows. It is suited to organic-solvent formulations and selectivity-focused experiments, but should not be used when a water-soluble compound, broad kinase inhibition, or an established clinical dosing protocol is required.
-
Isradipine (Dynacirc): L-Type Assay Logic
2026-08-07
Isradipine (Dynacirc) is examined here as an L-type calcium-channel probe rather than simply an antihypertensive compound. Learn how to interpret its vascular and neuronal effects alongside the subtype-selectivity findings of Sidach and Mintz.
-
DiscoveryProbe Protease Inhibitor Library: Translational Wor
2026-08-07
Harness the DiscoveryProbe Protease Inhibitor Library for robust, high throughput screening in apoptosis, cancer, and infectious disease research. This guide demystifies experimental setup, workflow optimization, and troubleshooting, directly linking the library’s capabilities to cutting-edge translational applications.
-
Latrunculin B in Translational Actin Dynamics: Evidence, Str
2026-08-06
Explore how Latrunculin B, a validated actin polymerization inhibitor, enables precise, transient disruption of the cytoskeleton for advanced cellular actin dynamics research. This thought-leadership article integrates mechanistic insights, strategic experimental guidance, and recent virological evidence to inform translational investigators seeking to leverage actin cytoskeleton manipulation for next-generation discovery.
-
Synergistic Apoptosis and Pyroptosis in RCC via SGI-1027 and
2026-08-06
This study demonstrates that combining SGI-1027, a DNMT1 inhibitor, with everolimus induces robust apoptosis and GSDME-dependent pyroptosis by triggering lysosomal membrane permeability in renal cell carcinoma (RCC) cells. These findings provide a new therapeutic approach for overcoming everolimus resistance in advanced RCC.
-
8-Chloroadenosine: Elevating RNA Metabolism Study Protocols
2026-08-05
8-Chloroadenosine stands out as a high-purity nucleoside analog for precise inhibition of RNA synthesis, streamlining experimental workflows in transcriptional regulation research. Its robust solubility profile and validated performance make it essential for dissecting complex lncRNA-mediated mechanisms in cancer studies.
-
Dantrolene Sodium Salt: Precision Ryanodine Receptor Antagon
2026-08-05
Dantrolene sodium salt, a nanomolar-potency ryanodine receptor antagonist, delivers precise, calmodulin-dependent control of intracellular calcium signaling for disease models and CRISPR workflows. This guide translates bench research into actionable protocols, troubleshooting, and next-generation applications for calcium-driven assays and synthetic lethality screens.